These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 37646649)
1. Molecular docking and molecular dynamics studies of natural products unravel potential inhibitors against OmpA of Singothu S; Devsani N; Jahidha Begum P; Maddi D; Bhandari V J Biomol Struct Dyn; 2024 Oct; 42(17):9064-9075. PubMed ID: 37646649 [TBL] [Abstract][Full Text] [Related]
2. Natural epiestriol-16 act as potential lead molecule against prospective molecular targets of multidrug resistant Acinetobacter baumannii-Insight from in silico modelling and in vitro investigations. Skariyachan S; Muddebihalkar AG; Badrinath V; Umashankar B; Eram D; Uttarkar A; Niranjan V Infect Genet Evol; 2020 Aug; 82():104314. PubMed ID: 32268193 [TBL] [Abstract][Full Text] [Related]
3. Screening of small molecules attenuating biofilm formation of Acinetobacter baumannii by inhibition of ompA promoter activity. Na SH; Jeon H; Oh MH; Kim YJ; Lee JC J Microbiol; 2021 Sep; 59(9):871-878. PubMed ID: 34449059 [TBL] [Abstract][Full Text] [Related]
4. Carbon fullerene acts as potential lead molecule against prospective molecular targets of biofilm-producing multidrug-resistant Skariyachan S; Gopal D; Kadam SP; Muddebihalkar AG; Uttarkar A; Niranjan V J Biomol Struct Dyn; 2021 Feb; 39(3):1121-1137. PubMed ID: 32036742 [TBL] [Abstract][Full Text] [Related]
5. Cyanobacterial compound Tolyporphine K as an inhibitor of Apo-PBP (penicillin-binding protein) in Gurnani M; Chauhan A; Ranjan A; Gopi P; Ghosh A; Tuli HS; Haque S; Pandya P; Lal R; Jindal T J Biomol Struct Dyn; 2024 May; 42(8):4133-4144. PubMed ID: 37261797 [TBL] [Abstract][Full Text] [Related]
6. Novel chiral phthalimides: Antimicrobial evaluation and docking study against Acinetobacter baumannii's OmpA protein. Abid R; Khan M; Siddique N; Khan SW; Khan RU; Zahoor M; Ullah R; Alotaibi A Comput Biol Med; 2024 Nov; 182():109099. PubMed ID: 39265475 [TBL] [Abstract][Full Text] [Related]
7. Outer membrane protein A contributes to antimicrobial resistance of Acinetobacter baumannii through the OmpA-like domain. Kwon HI; Kim S; Oh MH; Na SH; Kim YJ; Jeon YH; Lee JC J Antimicrob Chemother; 2017 Nov; 72(11):3012-3015. PubMed ID: 28981866 [TBL] [Abstract][Full Text] [Related]
9. Moleculer dynamics simulaiton revealed reciever domain of Ahmad S; Shaker B; Ahmad F; Raza S; Azam SS J Biomol Struct Dyn; 2019 Jul; 37(11):2897-2912. PubMed ID: 30043709 [No Abstract] [Full Text] [Related]
10. Identification of novel natural MurD ligase inhibitors as potential antimicrobial agents targeting Tiwari P; Sharma P; Kumar M; Kapil A; Abdul Samath E; Kaur P J Biomol Struct Dyn; 2022; 40(24):14051-14066. PubMed ID: 34766874 [TBL] [Abstract][Full Text] [Related]
11. Identification of Potent Natural Resource Small Molecule Inhibitor to Control Rahaman A; Almalki AA; Rafeeq MM; Akhtar O; Anjum F; Mashraqi MM; Sain ZM; Alzamami A; Ahmad V; Zeng XA; Jamal QMS Molecules; 2021 Oct; 26(21):. PubMed ID: 34770925 [No Abstract] [Full Text] [Related]
12. Virtual screening and molecular simulation study of natural products database for lead identification of novel coronavirus main protease inhibitors. Tripathi N; Goel B; Bhardwaj N; Sahu B; Kumar H; Jain SK J Biomol Struct Dyn; 2022 May; 40(8):3655-3667. PubMed ID: 33213294 [TBL] [Abstract][Full Text] [Related]
13. Screening of potential lead molecules against prioritised targets of multi-drug-resistant-Acinetobacter baumannii - insights from molecular docking, molecular dynamic simulations and in vitro assays. Skariyachan S; Manjunath M; Bachappanavar N J Biomol Struct Dyn; 2019 Mar; 37(5):1146-1169. PubMed ID: 29529934 [TBL] [Abstract][Full Text] [Related]
14. Acinetobacter baumannii OmpA-like porins: functional characterization of bacterial physiology, antibiotic-resistance, and virulence. Scribano D; Cheri E; Pompilio A; Di Bonaventura G; Belli M; Cristina M; Sansone L; Zagaglia C; Sarshar M; Palamara AT; Ambrosi C Commun Biol; 2024 Aug; 7(1):948. PubMed ID: 39107399 [TBL] [Abstract][Full Text] [Related]
15. Computational exploration of natural compounds targeting Saha S; Ghosh M J Biomol Struct Dyn; 2024 Oct; 42(16):8256-8267. PubMed ID: 37578046 [No Abstract] [Full Text] [Related]
16. Antibiotic discovery with artificial intelligence for the treatment of Boulaamane Y; Molina Panadero I; Hmadcha A; Atalaya Rey C; Baammi S; El Allali A; Maurady A; Smani Y mSystems; 2024 Jun; 9(6):e0032524. PubMed ID: 38700330 [TBL] [Abstract][Full Text] [Related]
17. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations. Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832 [TBL] [Abstract][Full Text] [Related]
18. In silico high-throughput virtual screening and molecular dynamics simulation study to identify inhibitor for AdeABC efflux pump of Acinetobacter baumannii. Verma P; Tiwari M; Tiwari V J Biomol Struct Dyn; 2018 Apr; 36(5):1182-1194. PubMed ID: 28393677 [TBL] [Abstract][Full Text] [Related]
19. OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii. Lin MF; Tsai PW; Chen JY; Lin YY; Lan CY PLoS One; 2015; 10(10):e0141107. PubMed ID: 26484669 [TBL] [Abstract][Full Text] [Related]
20. Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection. Nie D; Hu Y; Chen Z; Li M; Hou Z; Luo X; Mao X; Xue X J Biomed Sci; 2020 Jan; 27(1):26. PubMed ID: 31954394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]